A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TJ-100) in Subjects with Moderate Crohn's Disease.
Phase of Trial: Phase II
Latest Information Update: 03 Feb 2015
Price : $35 *
At a glance
- Drugs TJ 100 (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 02 Feb 2015 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 25 Sep 2014 According to the University Hospital Medical Information Network - Japan record, status changed from recruiting to active, no longer recruiting.
- 19 Dec 2012 New trial record